Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

In silico Identification of SFRP1 as a Hypermethylated Gene in Colorectal Cancers

  • Kim, Jongbum (Department of Bioinformatics and Life Science, Soongsil University) ;
  • Kim, Sangsoo (Department of Bioinformatics and Life Science, Soongsil University)
  • Received : 2014.10.17
  • Accepted : 2014.11.19
  • Published : 2014.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Aberrant DNA methylation, as an epigenetic marker of cancer, influences tumor development and progression. We downloaded publicly available DNA methylation and gene expression datasets of matched cancer and normal pairs from the Cancer Genome Atlas Data Portal and performed a systematic computational analysis. This study has three aims to screen genes that show hypermethylation and downregulated patterns in colorectal cancers, to identify differentially methylated regions in one of these genes, SFRP1, and to test whether the SFRP genes affect survival or not. Our results show that 31 hypermethylated genes had a negative correlation with gene expression. Among them, SFRP1 had a differentially methylated pattern at each methylation site. We also show that SFRP1 may be a potential biomarker for colorectal cancer survival.

Keywords

References

  1. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007;447:799-816. https://doi.org/10.1038/nature05874
  2. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-1159. https://doi.org/10.1056/NEJMra072067
  3. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986;321:209-213. https://doi.org/10.1038/321209a0
  4. Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 2010;19:698-711. https://doi.org/10.1016/j.devcel.2010.10.005
  5. Foster SA, Wong DJ, Barrett MT, Galloway DA. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 1998;18:1793-1801. https://doi.org/10.1128/MCB.18.4.1793
  6. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001;10:687-692. https://doi.org/10.1093/hmg/10.7.687
  7. Issa JP. DNA methylation as a therapeutic target in cancer. Clin Cancer Res 2007;13:1634-1637. https://doi.org/10.1158/1078-0432.CCR-06-2076
  8. Levenson VV, Melnikov AA. DNA methylation as clinically useful biomarkers-light at the end of the tunnel. Pharmaceuticals (Basel) 2012;5:94-113. https://doi.org/10.3390/ph5010094
  9. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010;11:587. https://doi.org/10.1186/1471-2105-11-587
  10. Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, et al. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 2006;25:3479-3488. https://doi.org/10.1038/sj.onc.1209386
  11. Qi J, Zhu YQ, Luo J, Tao WH. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 2006;12:7113-7117. https://doi.org/10.3748/wjg.v12.i44.7113
  12. Kinoshita T, Nomoto S, Kodera Y, Koike M, Fujiwara M, Nakao A. Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer. Hepatogastroenterology 2011;58:1051-1056.
  13. Bu XM, Zhao CH, Zhang N, Gao F, Lin S, Dai XW. Hypermethylation and aberrant expression of secreted frizzled- related protein genes in pancreatic cancer. World J Gastroenterol 2008;14:3421-3424. https://doi.org/10.3748/wjg.14.3421

Cited by

  1. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma vol.22, pp.47, 2016, https://doi.org/10.3748/wjg.v22.i47.10325
  2. Hilbert-Schmidt and Sobol sensitivity indices for static and time series Wnt signaling measurements in colorectal cancer - part A vol.11, pp.1, 2017, https://doi.org/10.1186/s12918-017-0488-z
  3. Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors vol.39, pp.5, 2017, https://doi.org/10.1177/1010428317701654
  4. in plasma samples pp.1559-2308, 2017, https://doi.org/10.1080/15592294.2017.1356957
  5. Methylation of secreted frizzled-related protein 1 (SFRP1) promoter downregulates Wnt/β-catenin activity in keloids vol.49, pp.2, 2018, https://doi.org/10.1007/s10735-018-9758-3